Literature DB >> 20202579

Hepatic complications of obesity.

Anna Mae Diehl1.   

Abstract

Obesity is associated with a spectrum of chronic liver disease. Because obesity increases the risk for advanced forms of liver disease (ie, cirrhosis and liver cancer), the obesity epidemic is emerging as a major factor underlying the burden of liver disease in the United States and many other countries. This article reviews mechanisms that mediate the pathogenesis of obesity-related liver disease, summarizes clinical evidence that demonstrates obesity-related liver disease can be life-threatening, and discusses whether or not treatments for obesity or related comorbidities impact liver disease outcomes. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202579     DOI: 10.1016/j.gtc.2009.12.001

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  21 in total

Review 1.  Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.

Authors:  Hiroyasu Sakai; Yohei Shirakami; Masahito Shimizu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

3.  P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice.

Authors:  Saurabh Chatterjee; Ritu Rana; Jean Corbett; Maria B Kadiiska; Joyce Goldstein; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2012-02-15       Impact factor: 7.376

4.  Resistin expression correlates with steatohepatitis in morbidly obese patients.

Authors:  Claire R Edwards; A Katharine Hindle; Patricia S Latham; Sidney W Fu; Fred J Brody
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

Review 5.  Obesity, inflammation, and liver cancer.

Authors:  Beicheng Sun; Michael Karin
Journal:  J Hepatol       Date:  2011-11-25       Impact factor: 25.083

6.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

7.  The effect of bariatric surgery on psychiatric course among patients with bipolar disorder.

Authors:  Ameena T Ahmed; E Margaret Warton; Catherine A Schaefer; Ling Shen; Roger S McIntyre
Journal:  Bipolar Disord       Date:  2013-08-05       Impact factor: 6.744

8.  Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.

Authors:  Jeanette M Tetrault; Janet P Tate; Kathleen A McGinnis; Joseph L Goulet; Lynn E Sullivan; Kendall Bryant; Amy C Justice; David A Fiellin
Journal:  Alcohol Clin Exp Res       Date:  2011-07-28       Impact factor: 3.455

Review 9.  Bariatric and metabolic surgery: a shift in eligibility and success criteria.

Authors:  Gema Frühbeck
Journal:  Nat Rev Endocrinol       Date:  2015-06-09       Impact factor: 43.330

10.  Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice.

Authors:  Liang Sheng; Bijie Jiang; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-08-27       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.